drugset / Trial / NCT01794169
Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether Azacitidine consolidation is superior to standard DA consolidation treatment of acute myeloid leukemia in first complete remission in elderly patients.
Timeline
- Start
- 2013-03
- Primary completion
- 2015-09
- Completion
- 2018-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azacitidine | Other / unclassified | 75 mg/m2 | Subcutaneous |
| Comparator | Cytarabine | Small molecule | 200 mg | Intravenous |
| Comparator | Cytarabine | Small molecule | 1000 mg/m2 | Intravenous |
| Comparator | Daunorubicin | Small molecule | 45 mg/m2 | Intravenous |